These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7533659)

  • 1. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor.
    Kleinerman DI; Troncoso P; Lin SH; Pisters LL; Sherwood ER; Brooks T; von Eschenbach AC; Hsieh JT
    Cancer Res; 1995 Mar; 55(6):1215-20. PubMed ID: 7533659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches.
    Hsieh JT; Luo W; Song W; Wang Y; Kleinerman DI; Van NT; Lin SH
    Cancer Res; 1995 Jan; 55(1):190-7. PubMed ID: 7805032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
    Lin SH; Pu YS
    Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
    Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
    Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate.
    Makarovskiy AN; Pu YS; Lo P; Earley K; Paglia M; Hixson DC; Lin SH
    Oncogene; 1999 May; 18(21):3252-60. PubMed ID: 10359531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.
    Kleinerman DI; Dinney CP; Zhang WW; Lin SH; Van NT; Hsieh JT
    Cancer Res; 1996 Aug; 56(15):3431-5. PubMed ID: 8758907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
    Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
    Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis.
    Chen N; Szentirmay MN; Pawar SA; Sirito M; Wang J; Wang Z; Zhai Q; Yang HX; Peehl DM; Ware JL; Sawadogo M
    Oncogene; 2006 Jan; 25(4):579-87. PubMed ID: 16186802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.
    Williams YN; Masuda M; Sakurai-Yageta M; Maruyama T; Shibuya M; Murakami Y
    Oncogene; 2006 Mar; 25(10):1446-53. PubMed ID: 16261159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
    Ruiz M; Troncoso P; Bruns C; Bar-Eli M
    Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
    Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
    Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
    Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
    J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.